THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 27 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $409,000 | -7.0% | 430,000 | 0.0% | 0.05% | -14.5% |
| Q1 2021 | $440,000 | +8.4% | 430,000 | 0.0% | 0.06% | -12.7% |
| Q4 2020 | $406,000 | -23.4% | 430,000 | -28.3% | 0.06% | -33.7% |
| Q3 2020 | $530,000 | -9.1% | 600,000 | 0.0% | 0.10% | -28.6% |
| Q2 2020 | $583,000 | -0.3% | 600,000 | 0.0% | 0.13% | +51.1% |
| Q1 2020 | $585,000 | -5.2% | 600,000 | 0.0% | 0.09% | +23.9% |
| Q4 2019 | $617,000 | +11.2% | 600,000 | 0.0% | 0.07% | +14.5% |
| Q3 2019 | $555,000 | +59.9% | 600,000 | +50.0% | 0.06% | +67.6% |
| Q2 2019 | $347,000 | – | 400,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 6,000,000 | $5,827,000 | 3.55% |
| DeepCurrents Investment Group LLC | 21,223,000 | $20,803,000 | 1.80% |
| ZAZOVE ASSOCIATES LLC | 19,230,000 | $18,725,000 | 1.77% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 1.61% |
| Castle Creek Arbitrage, LLC | 5,149,000 | $5,015,000 | 1.47% |
| LINDEN ADVISORS LP | 62,688,000 | $61,071,000 | 1.40% |
| Verition Fund Management LLC | 10,817,000 | $10,504,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $23,451,000 | 0.32% |
| Baupost Group | 30,000,000 | $29,213,000 | 0.24% |
| SSI INVESTMENT MANAGEMENT LLC | 2,763,000 | $2,676,000 | 0.22% |